Cargando…
Transcription factor 4 (TCF4) expression predicts clinical outcome in RUNX1 mutated and translocated acute myeloid leukemia
Autores principales: | in 't Hout, Florentien E. M., Gerritsen, Mylène, Bullinger, Lars, van der Reijden, Bert A., Huls, Gerwin, Vellenga, Edo, Jansen, Joop H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556620/ https://www.ncbi.nlm.nih.gov/pubmed/33054062 http://dx.doi.org/10.3324/haematol.2019.232827 |
Ejemplares similares
-
P455: RUNX1 DIRECTLY BINDS AND REGULATES THE TCF4 PROMOTER
por: Gerritsen, Mylene, et al.
Publicado: (2023) -
The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis
por: de Boer, Bauke, et al.
Publicado: (2020) -
Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft Models
por: Sontakke, Pallavi, et al.
Publicado: (2016) -
The First Case of Acute Myeloid Leukemia With a Novel Five-way Variant Translocation of RUNX1–RUNX1T1
por: Jo, Yong Hun, et al.
Publicado: (2023) -
Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases
por: Han, Lina, et al.
Publicado: (2010)